Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohan Krishnappa"'
Autor:
Mohan Krishnappa, Varun Ahuja
Publikováno v:
Journal of Applied Toxicology. 42:154-167
The use of pharmaceutical drugs has provided a cure for many diseases. However, unintended exposure to drugs in the manufacturing workplace can cause significant health hazards to workers. It is important to protect the workforce from these deleterio
Autor:
Varun Ahuja, Mohan Krishnappa
Publikováno v:
The International journal of risksafety in medicine. 33(1)
BACKGROUND: When more than one drug is manufactured at a shared facility or equipment in pharmaceutical manufacturing, the potential carry-over of the retained residue of existing drug product on product contact parts of the equipment to the next pro
Autor:
Chaitra Jayarao, Mohan Krishnappa, Govind Chandrayan, Bibhuti Ranjan, Avinash Jadhav, Prabhakar Y Bhoite, Sujatha Narayanan, Ashok Kumar Dubey, Manish Kumar Jain, Deepika Pandey Tiwari, Deepa Venkataramulu
Publikováno v:
Toxicology Research and Application, Vol 3 (2019)
Galactooligosaccharides (GOS) used as prebiotics are one of the major constituents of the infant milk formulas. GOS (Gossence™) is produced by a patented process of biotransformation of lactose; hence toxicology studies were carried out to assess i
Autor:
Ashok Kumar Dubey, Moninder Kaur, Prabhakar Y Bhoite, Govind Chandrayan, Chandrashekara Vishwanath, Nataraju Javaregowda, Mohan Krishnappa, Manish Kumar Jain, Deepika Pandey Tiwari
Publikováno v:
Toxicology Research and Application, Vol 4 (2020)
Gossence™ (galactooligosaccharide; GOS) is a prebiotics and used as one of the major constituents in infant milk formulas that act as a functional food. Gossence is manufactured by Tata Chemicals Ltd, India, through a patented process of biotransfo
Autor:
Srinath Satyanarayana, Devesh Gupta, Balaji Naik, Mohan Krishnappa, Puneet Dewan, Vikas Inamdar, Kumaraswamy Lal, Sangamesh Doddamani, Ajay Kumar Mv
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 59(4)
BACKGROUND: HIV testing of persons referred for tuberculosis diagnosis TB suspects) is recommended by World Health Organization but is not a policy in India, where HIV prevalence among TB suspects has never been reported. The current Indian policy of